| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |